 | • レポートコード：QFJ1-5846 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、転移性骨疾患薬物治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、ビスフォスフォネート、アヘン剤療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・転移性骨疾患薬物治療の市場動向 ・企業の競争状況、市場シェア ・転移性骨疾患薬物治療の種類別市場規模と予測2016-2027（化学療法、ホルモン療法、ビスフォスフォネート、アヘン剤療法、免疫療法） ・転移性骨疾患薬物治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・転移性骨疾患薬物治療の北米市場規模2016-2027（アメリカ、カナダ） ・転移性骨疾患薬物治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・転移性骨疾患薬物治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・転移性骨疾患薬物治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・転移性骨疾患薬物治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Merck & Co、Roche、Novartis、Eli Lilly and Company、Bayer、Fresenius Kabi、BTG plc、Boston Scientific、Medtronic） ・結論 |
Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs.
Market Analysis and Insights: Global Medication Treatment of Metastatic Bone Disease Market
The global Medication Treatment of Metastatic Bone Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medication Treatment of Metastatic Bone Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medication Treatment of Metastatic Bone Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medication Treatment of Metastatic Bone Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medication Treatment of Metastatic Bone Disease market.
Global Medication Treatment of Metastatic Bone Disease Scope and Market Size
Medication Treatment of Metastatic Bone Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medication Treatment of Metastatic Bone Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Hormone Therapy
Bisphosphonates
Opiate Therapy
Immunotherapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Merck & Co
Roche
Novartis
Eli Lilly and Company
Bayer
Fresenius Kabi
BTG plc
Boston Scientific
Medtronic
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication Treatment of Metastatic Bone Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Hormone Therapy
1.2.4 Bisphosphonates
1.2.5 Opiate Therapy
1.2.6 Immunotherapy
1.3 Market by Application
1.3.1 Global Medication Treatment of Metastatic Bone Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Medication Treatment of Metastatic Bone Disease Market Perspective (2016-2027)
2.2 Medication Treatment of Metastatic Bone Disease Growth Trends by Regions
2.2.1 Medication Treatment of Metastatic Bone Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Medication Treatment of Metastatic Bone Disease Historic Market Share by Regions (2016-2021)
2.2.3 Medication Treatment of Metastatic Bone Disease Forecasted Market Size by Regions (2022-2027)
2.3 Medication Treatment of Metastatic Bone Disease Industry Dynamic
2.3.1 Medication Treatment of Metastatic Bone Disease Market Trends
2.3.2 Medication Treatment of Metastatic Bone Disease Market Drivers
2.3.3 Medication Treatment of Metastatic Bone Disease Market Challenges
2.3.4 Medication Treatment of Metastatic Bone Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medication Treatment of Metastatic Bone Disease Players by Revenue
3.1.1 Global Top Medication Treatment of Metastatic Bone Disease Players by Revenue (2016-2021)
3.1.2 Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Players (2016-2021)
3.2 Global Medication Treatment of Metastatic Bone Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Medication Treatment of Metastatic Bone Disease Revenue
3.4 Global Medication Treatment of Metastatic Bone Disease Market Concentration Ratio
3.4.1 Global Medication Treatment of Metastatic Bone Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication Treatment of Metastatic Bone Disease Revenue in 2020
3.5 Medication Treatment of Metastatic Bone Disease Key Players Head office and Area Served
3.6 Key Players Medication Treatment of Metastatic Bone Disease Product Solution and Service
3.7 Date of Enter into Medication Treatment of Metastatic Bone Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medication Treatment of Metastatic Bone Disease Breakdown Data by Type
4.1 Global Medication Treatment of Metastatic Bone Disease Historic Market Size by Type (2016-2021)
4.2 Global Medication Treatment of Metastatic Bone Disease Forecasted Market Size by Type (2022-2027)
5 Medication Treatment of Metastatic Bone Disease Breakdown Data by Application
5.1 Global Medication Treatment of Metastatic Bone Disease Historic Market Size by Application (2016-2021)
5.2 Global Medication Treatment of Metastatic Bone Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Medication Treatment of Metastatic Bone Disease Market Size (2016-2027)
6.2 North America Medication Treatment of Metastatic Bone Disease Market Size by Type
6.2.1 North America Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021)
6.2.2 North America Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027)
6.2.3 North America Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2027)
6.3 North America Medication Treatment of Metastatic Bone Disease Market Size by Application
6.3.1 North America Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021)
6.3.2 North America Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027)
6.3.3 North America Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2027)
6.4 North America Medication Treatment of Metastatic Bone Disease Market Size by Country
6.4.1 North America Medication Treatment of Metastatic Bone Disease Market Size by Country (2016-2021)
6.4.2 North America Medication Treatment of Metastatic Bone Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Medication Treatment of Metastatic Bone Disease Market Size (2016-2027)
7.2 Europe Medication Treatment of Metastatic Bone Disease Market Size by Type
7.2.1 Europe Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021)
7.2.2 Europe Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027)
7.2.3 Europe Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2027)
7.3 Europe Medication Treatment of Metastatic Bone Disease Market Size by Application
7.3.1 Europe Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021)
7.3.2 Europe Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027)
7.3.3 Europe Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2027)
7.4 Europe Medication Treatment of Metastatic Bone Disease Market Size by Country
7.4.1 Europe Medication Treatment of Metastatic Bone Disease Market Size by Country (2016-2021)
7.4.2 Europe Medication Treatment of Metastatic Bone Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size (2016-2027)
8.2 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Type
8.2.1 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Application
8.3.1 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Region
8.4.1 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Medication Treatment of Metastatic Bone Disease Market Size (2016-2027)
9.2 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Type
9.2.1 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021)
9.2.2 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027)
9.2.3 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2027)
9.3 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Application
9.3.1 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021)
9.3.2 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027)
9.3.3 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2027)
9.4 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Country
9.4.1 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Country (2016-2021)
9.4.2 Latin America Medication Treatment of Metastatic Bone Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size (2016-2027)
10.2 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Type
10.2.1 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Application
10.3.1 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Country
10.4.1 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Medication Treatment of Metastatic Bone Disease Introduction
11.1.4 Amgen Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Medication Treatment of Metastatic Bone Disease Introduction
11.2.4 Merck & Co Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.2.5 Merck & Co Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Medication Treatment of Metastatic Bone Disease Introduction
11.3.4 Roche Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Medication Treatment of Metastatic Bone Disease Introduction
11.4.4 Novartis Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Medication Treatment of Metastatic Bone Disease Introduction
11.5.4 Eli Lilly and Company Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Medication Treatment of Metastatic Bone Disease Introduction
11.6.4 Bayer Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Details
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Medication Treatment of Metastatic Bone Disease Introduction
11.7.4 Fresenius Kabi Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.7.5 Fresenius Kabi Recent Development
11.8 BTG plc
11.8.1 BTG plc Company Details
11.8.2 BTG plc Business Overview
11.8.3 BTG plc Medication Treatment of Metastatic Bone Disease Introduction
11.8.4 BTG plc Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.8.5 BTG plc Recent Development
11.9 Boston Scientific
11.9.1 Boston Scientific Company Details
11.9.2 Boston Scientific Business Overview
11.9.3 Boston Scientific Medication Treatment of Metastatic Bone Disease Introduction
11.9.4 Boston Scientific Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.9.5 Boston Scientific Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Details
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Medication Treatment of Metastatic Bone Disease Introduction
11.10.4 Medtronic Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
11.10.5 Medtronic Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Medication Treatment of Metastatic Bone Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Hormone Therapy
Table 4. Key Players of Bisphosphonates
Table 5. Key Players of Opiate Therapy
Table 6. Key Players of Immunotherapy
Table 7. Global Medication Treatment of Metastatic Bone Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Medication Treatment of Metastatic Bone Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Medication Treatment of Metastatic Bone Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Medication Treatment of Metastatic Bone Disease Market Share by Regions (2016-2021)
Table 11. Global Medication Treatment of Metastatic Bone Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Medication Treatment of Metastatic Bone Disease Market Share by Regions (2022-2027)
Table 13. Medication Treatment of Metastatic Bone Disease Market Trends
Table 14. Medication Treatment of Metastatic Bone Disease Market Drivers
Table 15. Medication Treatment of Metastatic Bone Disease Market Challenges
Table 16. Medication Treatment of Metastatic Bone Disease Market Restraints
Table 17. Global Medication Treatment of Metastatic Bone Disease Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Medication Treatment of Metastatic Bone Disease Market Share by Players (2016-2021)
Table 19. Global Top Medication Treatment of Metastatic Bone Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medication Treatment of Metastatic Bone Disease as of 2020)
Table 20. Ranking of Global Top Medication Treatment of Metastatic Bone Disease Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Medication Treatment of Metastatic Bone Disease Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Medication Treatment of Metastatic Bone Disease Product Solution and Service
Table 24. Date of Enter into Medication Treatment of Metastatic Bone Disease Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Type (2016-2021)
Table 28. Global Medication Treatment of Metastatic Bone Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Medication Treatment of Metastatic Bone Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Application (2016-2021)
Table 32. Global Medication Treatment of Metastatic Bone Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Medication Treatment of Metastatic Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Medication Treatment of Metastatic Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Medication Treatment of Metastatic Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Medication Treatment of Metastatic Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Medication Treatment of Metastatic Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Medication Treatment of Metastatic Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size by Country (2022-2027) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Medication Treatment of Metastatic Bone Disease Product
Table 67. Amgen Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 68. Amgen Recent Development
Table 69. Merck & Co Company Details
Table 70. Merck & Co Business Overview
Table 71. Merck & Co Medication Treatment of Metastatic Bone Disease Product
Table 72. Merck & Co Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 73. Merck & Co Recent Development
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche Medication Treatment of Metastatic Bone Disease Product
Table 77. Roche Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 78. Roche Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Medication Treatment of Metastatic Bone Disease Product
Table 82. Novartis Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Eli Lilly and Company Company Details
Table 85. Eli Lilly and Company Business Overview
Table 86. Eli Lilly and Company Medication Treatment of Metastatic Bone Disease Product
Table 87. Eli Lilly and Company Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 88. Eli Lilly and Company Recent Development
Table 89. Bayer Company Details
Table 90. Bayer Business Overview
Table 91. Bayer Medication Treatment of Metastatic Bone Disease Product
Table 92. Bayer Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 93. Bayer Recent Development
Table 94. Fresenius Kabi Company Details
Table 95. Fresenius Kabi Business Overview
Table 96. Fresenius Kabi Medication Treatment of Metastatic Bone Disease Product
Table 97. Fresenius Kabi Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 98. Fresenius Kabi Recent Development
Table 99. BTG plc Company Details
Table 100. BTG plc Business Overview
Table 101. BTG plc Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 102. BTG plc Recent Development
Table 103. Boston Scientific Company Details
Table 104. Boston Scientific Business Overview
Table 105. Boston Scientific Medication Treatment of Metastatic Bone Disease Product
Table 106. Boston Scientific Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 107. Boston Scientific Recent Development
Table 108. Medtronic Company Details
Table 109. Medtronic Business Overview
Table 110. Medtronic Medication Treatment of Metastatic Bone Disease Product
Table 111. Medtronic Revenue in Medication Treatment of Metastatic Bone Disease Business (2016-2021) & (US$ Million)
Table 112. Medtronic Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medication Treatment of Metastatic Bone Disease Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Hormone Therapy Features
Figure 4. Bisphosphonates Features
Figure 5. Opiate Therapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Medication Treatment of Metastatic Bone Disease Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Medication Treatment of Metastatic Bone Disease Report Years Considered
Figure 12. Global Medication Treatment of Metastatic Bone Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Medication Treatment of Metastatic Bone Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Medication Treatment of Metastatic Bone Disease Market Share by Regions: 2020 VS 2027
Figure 15. Global Medication Treatment of Metastatic Bone Disease Market Share by Regions (2022-2027)
Figure 16. Global Medication Treatment of Metastatic Bone Disease Market Share by Players in 2020
Figure 17. Global Top Medication Treatment of Metastatic Bone Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medication Treatment of Metastatic Bone Disease as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Medication Treatment of Metastatic Bone Disease Revenue in 2020
Figure 19. Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Type (2016-2021)
Figure 20. Global Medication Treatment of Metastatic Bone Disease Revenue Market Share by Type (2022-2027)
Figure 21. North America Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Medication Treatment of Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 23. North America Medication Treatment of Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 24. North America Medication Treatment of Metastatic Bone Disease Market Share by Country (2016-2027)
Figure 25. United States Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Medication Treatment of Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 29. Europe Medication Treatment of Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 30. Europe Medication Treatment of Metastatic Bone Disease Market Share by Country (2016-2027)
Figure 31. Germany Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Medication Treatment of Metastatic Bone Disease Market Share by Region (2016-2027)
Figure 41. China Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Medication Treatment of Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 49. Latin America Medication Treatment of Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 50. Latin America Medication Treatment of Metastatic Bone Disease Market Share by Country (2016-2027)
Figure 51. Mexico Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Medication Treatment of Metastatic Bone Disease Market Share by Country (2016-2027)
Figure 57. Turkey Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Medication Treatment of Metastatic Bone Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Amgen Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 61. Merck & Co Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 66. Fresenius Kabi Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 67. BTG plc Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 68. Boston Scientific Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 69. Medtronic Revenue Growth Rate in Medication Treatment of Metastatic Bone Disease Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の転移性骨がん薬物治療市場規模・現状・予測（2021年-2027年） Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancer Market Analysis and Insights: Global Met…- 世界の転移性骨疾患市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Metastatic Bone Disea…
- 転移性骨腫瘍治療のグローバル市場調査 2019年 The global Metastatic Bone Tumor Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Metastatic Bone Tumor Treatment volume and value at global level, regional level and company level. From a …
- 世界の転移性黒色腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Metastatic Melanoma Treatment Market The global Metastatic Melanoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
- 世界の転移性乳がん治療市場規模・現状・予測（2021年-2027年） Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…